In the three independent datasets, we confirmed that PHLDA1 and MAML3 were highly expressed and AHNAK2 was lowly expressed in blood and left ventricle samples from DCM compared to control, indicating that the genetic mutation could lead to their abnormal expression. This evidence concerns the gene MAML3 and familial dilated cardiomyopathy.